Dr Laura Cleghorn
Laura is the Tuberculosis Portfolio Manager within the Drug Discovery Unit (DDU). She obtained her BSc (hons) in Chemistry from the University of Edinburgh, following this she became a medicinal chemist working at Organon Laboratories before moving to the University of Leeds to complete a PhD in chemistry. Laura joined the DDU in 2006 at the point of its inception, initially working as a medicinal chemist working on Human African Trypanosomiasis before changing focus to Tuberculosis (TB) in 2013. The purpose of her current role is to lead and work with a team of scientists internally and as a part of external consortia to discover new series that inhibit TB and develop them towards pre-clinical drug candidates against TB.